Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) Stock Price & Analysis
Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) — price $2.02 (0.00%), as of the Nov 20, 2026 trading session; market cap $35.8M.
Educational signal · not a buy or sell recommendation · How to read this
Zhong Yuan Bio-Technology Holdings Limited · ZHYBF
Zhong Yuan Bio-Technology Holdings Limited specializes in the development and marketing of nervonic acid-based health supplements within China, offering products such as Neuro Enhancer oils and a demyelination diagnostic kit. The company operates under the Muzhiyuan-Neuro Enhancer brand and is headquartered in Wan Chai, Hong Kong.
Price as of Nov 20, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $2.02 | |
| Change on the day | 0.00% | |
| Market capitalisation | $35.8M | |
| Price / earnings (trailing) | 118.82 | |
| Shares traded on the day | 130 |
Price & events
Other perspectives
Council score for Zhong Yuan Bio-Technology Holdings (ZHYBF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
5 lenses, 5 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 21, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 9, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 9, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 21, 2026, except a card that shows its own read date.
What is Zhong Yuan Bio-Technology Holdings (ZHYBF), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) is the company analyzed here. It employs 23 people. In Q4 FY2024 it reported revenue of $348,878 and net income of -$73,639. The market values it at $35.8M.
What do the latest results show for Zhong Yuan Bio-Technology Holdings (ZHYBF)?
Short answer · as of
The most recent reported quarter, Q4 FY2024, carried revenue of $348,878.
Quarterly income statement — 1 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 FY2024 | $348,878 | -$73,639 | -$0.0042 (diluted) |
What are the financial strengths and risks for Zhong Yuan Bio-Technology Holdings (ZHYBF)?
Short answer
The distress and quality screens read Altman Z 5.74 · Piotroski F 7. Trailing ratios: ROA 6.3% · current ratio 0.82.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held ZHYBF in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported ZHYBF in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What Investors Ask About Zhong Yuan Bio-Technology Holdings (ZHYBF)
These answers are editorial: 1 of these 8 answers is drawn from the ZHYBF research dossier (written Jun 14, 2026 by gemini-2.5-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is ZHYBF a good stock to buy?
Stock Expert AI does not rate ZHYBF buy, sell or hold. Zhong Yuan Bio-Technology Holdings Limited has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the ZHYBF stock price today?
The last price recorded for Zhong Yuan Bio-Technology Holdings Limited (ZHYBF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What are the main risks for ZHYBF?
ZHYBF faces several key risks, including intense competition in the Chinese health supplement market from both local and international brands, which could pressure pricing and market share.
What are the key factors to evaluate for ZHYBF?
Evaluate ZHYBF on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. Not financial advice.
How frequently does ZHYBF data refresh on this page?
ZHYBF's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven ZHYBF's recent stock price performance?
Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ZHYBF overvalued or undervalued right now?
The trailing P/E of Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research ZHYBF before investing?
Before investing in Zhong Yuan Bio-Technology Holdings Limited (ZHYBF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 12 figures on this page — 10 from Financial Modeling Prep (FMP) and 2 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com